28
Publications
2.9K
Citations
22
H-Index
1993
Active since
Daniel A. Erlanson is an author at Sunesis (United States) specializing in medicine, biochemistry, and drug discovery.
Top concepts
MedicineBiochemistryDrug DiscoveryNatural SciencesPharmacologyMolecular BiologyChemical BiologyMedicinal ChemistryChemistryMolecular Docking
Publications per year
1993–2021
28
28
Site-directed ligand discovery
Daniel A. Erlanson, Andrew C. Braisted, D.R. Raphael et al. · Proceedings of the National Academy of Sciences · 2000 · 461 citations · Full text
Unexpected Effect of Proton Pump Inhibitors
Yohannes T. Ghebremariam, Paea LePendu, Jerry C. Lee et al. · Circulation · 2013 · 248 citations · Full text
György M. Keserű, Daniel A. Erlanson, György G. Ferenczy et al. · Journal of Medicinal Chemistry · 2016 · 225 citations
Pharmaceutical Research, Hit Identification, Molecular Biology +20
In situ assembly of enzyme inhibitors using extended tethering
Daniel A. Erlanson, Joni W. Lam, Christian Wiesmann et al. · Nature Biotechnology · 2003 · 196 citations
Rows per page
1–5 of 28